The University of Minnesota is on its way to becoming one of the top three research universities in the country, but without state-of-the-art facilities this goal was out of reach. The university is at the cutting edge of immune system, brain and Alzheimer’s research, but until now the researchers in these fields were housed in various department-specific buildings, thus decreasing synergy amongst the fields and making the university less attractive to valuable researchers who need interdisciplinary support.
In order to solve this problem, H2I Group, Inc.; general contractor, Kraus-Anderson; and architect, Perkins and Will worked side by side to create the new, $79.3 million, 115,000 square foot Medical Biosciences Building, which now houses 210 researchers and 25 principle investigators. These researchers specialize in the brain, immune system and Alzheimer’s. The new medical bioscience laboratory allows researchers to work side-by-side and across disciplines to further medical research. This state of the art laboratory is critical to the state of Minnesota and the research community at the University of Minnesota because it creates attractive, new jobs for highly qualified researchers. This is the second building the university’s new “biomedical discovery district,” a $300 million dollar project funded by a combination of state bonds and private donors.
H2I's ability to work cohesively with the project team to make their vision a reality resulted in the opening of the brand new Medical Bioscience Laboratory Building on December 1, 2009. For Haldeman-Homme, the project included the furnishings for multiple laboratories. These furnishings, by H2I Group Inc, included 500 Distinction Tables and 16 fume hoods. Researchers expect the new building and state-of-the-art laboratories to provide increased synergy amongst various fields of research. They hope to attract valuable researchers in order to proliferate ideas and protect them by keeping them in state. With the new laboratory, the University of Minnesota and the state hope to continue their innovative reputation, and stay at the forefront of biomedical advances.